Makes flavor and specialty food ingredients, scent products, and biotechnology-based ingredients for food and beverage, personal-care and household-product, and health-product manufacturers.
10-K for FY2025, filed Feb 27, 2026Our Taste segment consists of the development and production of a range of flavor compounds and natural taste solutions that are ultimately…View ↗
Our Food Ingredients segment consists of a diversified portfolio across natural, artificial and plant-based specialty food ingredients that…View ↗
Our Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food…View ↗
Our Scent segment creates fragrance compounds and fragrance ingredients that are integral elements in the world’s finest perfumes and…View ↗
The markets for our products are part of a larger market that supplies a wide variety of ingredients and compounds used in consumer…View ↗
Manufacturers buy IFF’s products under approved contracts or purchase orders; payment follows customer terms, which can vary.
10-K for FY2025, filed Feb 27, 2026
10-K for FY2025, filed Feb 27, 2026
FY2025 revenue by reportable segment ↗$10.9B
10-K for FY2025, filed Feb 27, 2026
$10.9B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Taste
Sold outright
10-K for FY2025, filed Feb 27, 2026 |
23% |
Taste, FY2025
$2.5B Sources
|
Sold outright |
|
Food Ingredients
Sold outright
10-K for FY2025, filed Feb 27, 2026 |
30% |
Food Ingredients, FY2025
$3.3B Sources
|
Sold outright |
|
Health & Biosciences
Sold outright
10-K for FY2025, filed Feb 27, 2026 |
21%
FY2022: 19%
|
Health & Biosciences, FY2025
$2.3B Sources
|
Sold outright |
|
Scent
Sold outright
10-K for FY2025, filed Feb 27, 2026 |
23%
FY2022: 19%
|
Scent, FY2025
$2.5B Sources
|
Sold outright |
|
Pharma Solutions
Sold outright
|
3.4%
FY2022: 7.8%
|
Pharma Solutions, FY2025
$369M Sources
|
Sold outright |
Sells mainly to manufacturers of food and beverages, personal-care and household products, and health and nutrition products. Its customer base includes multinational consumer-products companies as well as small and midsized businesses.
10-K for FY2025, filed Feb 27, 2026
10-Q for Q3 FY2026, filed Nov 3, 2026
−$55MView ↗
8-K, filed Aug 4, 2026
As announced on May 29, 2026, International Flavors & Fragrances Inc. (“IFF” or the “Company”) entered into a Purchase Agreement to sell…View ↗
Flat. Revenue was $10.9B in FY2025, about the same as the $11.7B of FY2021.
Pharma Solutions divestiture
The older report described pharmaceutical excipients and specialty and industrial uses in Pharma Solutions; the latest says the business was divested, removing it from the current portfolio.
10-K for FY2022, filed Feb 27, 2023 10-K for FY2025, filed Feb 27, 2026Our Pharma Solutions segment produces, among other things, a vast portfolio of cellulosics and seaweed-based pharmaceutical excipients…View ↗
Our former Pharma Solutions segment produced, among other things, a vast portfolio of cellulosics and seaweed-based pharmaceutical…View ↗
Nourish split into two segments
Food and flavor products formerly grouped in Nourish are presented in separate Taste and Food Ingredients segments in the latest report.
10-K for FY2022, filed Feb 27, 2023 10-K for FY2025, filed Feb 27, 2026Our business currently consists of four segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. As part of our ongoing…View ↗
Our Nourish segment consists of an innovative and broad portfolio of natural-based ingredients to enhance nutritional value, texture and…View ↗
Flavors include a range of flavor compounds and natural taste solutions that are ultimately used by our customers in savory products…View ↗
During the year ended December 31, 2025, our business consisted of five segments: Taste, Food Ingredients, Health & Biosciences, Scent and…View ↗
Our Taste segment consists of the development and production of a range of flavor compounds and natural taste solutions that are ultimately…View ↗
Our Food Ingredients segment consists of a diversified portfolio across natural, artificial and plant-based specialty food ingredients that…View ↗
Competes with Givaudan, Novonesis, DSM-Firmenich, Symrise, Kerry, and ADM
10-K for FY2025, filed Feb 27, 2026The market for our products is highly competitive. Our main competitors consist of (1) other large global companies, such as Givaudan…View ↗
Loading...